In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in non-small cell lung cancer, non-Hodgkin lymphoma, Ewing sarcoma, and neuroblastoma.
In this post, several experts describe what Hodgkin lymphoma survivors who received mantle radiation should know about their increased breast cancer risk, including what to know about screening and monitoring for signs of breast cancer.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s studies explore adding nimotuzumab to chemotherapy to treat KRAS wild-type pancreatic cancer and adding ibrutinib to standard care for older adults with mantle cell lymphoma.
In this podcast, Dr. Christopher Flowers discusses research from the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition, including studies evaluating new treatments for diffuse large B-cell lymphoma and an overview of a session on improving equity in cancer clinical trials.
Dr. Craig A. Portell discusses what CAR T-cell therapy is, how it works, what its common side effects are, and how it’s changing the landscape of how some types of cancers are treated.
Be The Match, the national bone marrow transplant registry, needs people of different racial and ethnic backgrounds to volunteer as donors. Learn why having diversity in the registry is important, what disparities exist, and how to sign up.
In this podcast, Dr. Michael Williams discusses studies and a report on the treatment of leukemia and lymphoma presented at last month’s ASH Annual Meeting.
In this month’s "From the Editor’s Desk," Dr. Lidia Schapira reflects on the difficulties of 2020 during the COVID-19 pandemic and how people with cancer can find hope as 2021 begins.
In this post, teenage cancer survivor Andrés Nachón describes what it was like being diagnosed with cancer at age 17, and how his faith and love for basketball helped him cope.
In this podcast, Cancer.Net Associate Editors discuss new and emerging research in primary and secondary brain tumors and several types of lymphoma presented at the ASCO20 Virtual Scientific Program.
